Oncology
12 Questions with David Long

12 Questions with David Long

David Long leads the Oncology Business Unit at MSD in the UK and brings a wealth of experience from his 20 years within the organisation, having held a variety of local, regional and global

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. Axsome breaks new ground in Alzheimer's with Auvelity OK
  2. Merck partners Remepy in PDURS-focused alliance
  3. Teva makes its first M&A play in years, buying Emalex
  4. UK study finds clue to rising cancer rates in younger people
  5. Boehringer/Zealand dual-acting drug causes 16.6% weight loss

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

Patients
Anatomical graphic concept of a liver in 3D

Rewriting the MASLD playbook

Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.

more

R&D

more